Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballentine

Showing results (171-180 of 453) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Disparities in treatment and outcome for renal cell cancer among older black and white patientsSonja I Berndt, H Ballentine Carter, Mark P Schoenberg, et al.
JAMA Oncology|July 18, 2017
Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk GroupHiten D Patel, Jeffrey J Tosoian, H Ballentine Carter, et al.
Urologic Oncology|December 31, 2017
Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalizationCarling Cheung, Hiten D Patel, Patricia Landis, et al.
JAMA Oncology|June 1, 2018
Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer-ReplyHiten D Patel, Jeffrey J Tosoian, H Ballentine Carter, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1979
Warfarin enantiomer disposition: determination by stereoselective radioimmunoassayC E Cook, N H Ballentine, T B Seltzman, et al.
The Patient|June 13, 2014
Characteristics and experiences of patients with localized prostate cancer who left an active surveillance programZackary D Berger, Jonathan C Yeh, H Ballentine Carter, et al.
BJU International|November 19, 2011
The relationship between prostate volume and prostate-specific antigen variability: data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance ProgramJohn H Nichols, Stacy Loeb, E Jeffrey Metter, et al.
Journal of the National Cancer Institute|March 2, 2006
Delayed versus immediate surgical intervention and prostate cancer outcomeChristopher Warlick, Bruce J Trock, Patricia Landis, et al.
American Journal of Therapeutics|June 11, 2010
Benzodiazepine-associated atrioventricular blockAnna M Arroyo Plasencia, Lynn M Ballentine, James B Mowry, et al.
The Journal of Urology|May 18, 2013
Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysisAdam C Reese, Patricia Landis, Misop Han, et al.
Pageof 46

Showing results (171-180 of 453) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Disparities in treatment and outcome for renal cell cancer among older black and white patientsSonja I Berndt, H Ballentine Carter, Mark P Schoenberg, et al.
JAMA Oncology|July 18, 2017
Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk GroupHiten D Patel, Jeffrey J Tosoian, H Ballentine Carter, et al.
Urologic Oncology|December 31, 2017
Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalizationCarling Cheung, Hiten D Patel, Patricia Landis, et al.
JAMA Oncology|June 1, 2018
Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer-ReplyHiten D Patel, Jeffrey J Tosoian, H Ballentine Carter, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1979
Warfarin enantiomer disposition: determination by stereoselective radioimmunoassayC E Cook, N H Ballentine, T B Seltzman, et al.
The Patient|June 13, 2014
Characteristics and experiences of patients with localized prostate cancer who left an active surveillance programZackary D Berger, Jonathan C Yeh, H Ballentine Carter, et al.
BJU International|November 19, 2011
The relationship between prostate volume and prostate-specific antigen variability: data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance ProgramJohn H Nichols, Stacy Loeb, E Jeffrey Metter, et al.
Journal of the National Cancer Institute|March 2, 2006
Delayed versus immediate surgical intervention and prostate cancer outcomeChristopher Warlick, Bruce J Trock, Patricia Landis, et al.
American Journal of Therapeutics|June 11, 2010
Benzodiazepine-associated atrioventricular blockAnna M Arroyo Plasencia, Lynn M Ballentine, James B Mowry, et al.
The Journal of Urology|May 18, 2013
Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysisAdam C Reese, Patricia Landis, Misop Han, et al.
Pageof 46